Cyclerion Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$2.95(as of Apr 23, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Cyclerion Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$2.95
Ticker SymbolCYCN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees1
CountyUSA
Market Cap$13.3M
EBIDTA-9.6M
10-Day Moving Average3.01
P/E Ratio-2.70
20-Day Moving Average3.12
Forward P/E Ratio0.00
50-Day Moving Average2.09
Earnings per Share-1.11
200-Day Moving Average2.08
Profit Margin-77.95%
RSI52.79
Shares Outstanding4.3M
ATR0.52
52-Week High8.48
Volume147,519
52-Week Low1.03
Most Recent Support Level2.83
Book Value9.1M
Most Recent Resistance Level3.14
P/B Ratio1.05
Upper Keltner4.28
P/S Ratio4.59
Lower Keltner1.95
Debt-to-Equity Ratio4.28
Next Earnings DateUnknown
Cash Surplus2.3M
Next Ex-Dividend DateUnknown

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Cyclerion Therapeutics Inc In Our Stock Scanner

As of Apr 24, 2026
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.